Stem Cell Therapy International, Inc. and Histostem Korea Announce Providing Hematopoietic Stem Cell to Queen Mary …
TAMPA, FL–(Marketwire – 11/05/09) – Stem Cell Therapy International Inc. (OTC.BB: SCII – News ) and its soon to be subsidiary, Histostem Ltd. of South Korea (”Histostem”), announced that they recently supplied hematopoietic stem cells to The Queen Mary Hospital of the University of Hong Kong, China, for treatment of Leukemia patients. As reported October 29, 2009 in the Korean Medical …
[Read the full article here]Related News:
Stem Cell Therapy International, Inc. And Histostem Korea Announce Providing Hematopoietic Stem Cell To Queen Mary Hospital, Hong Kong
Stem Cell Therapy International to merge with Histostem Korea
Stem Cell Therapy International, Inc. and Histostem Korea Announce $5 Million Financing Commitment